Oral Anticoagulation in Patients with Chronic Liver Disease

Oral Anticoagulation in Patients with Chronic Liver Disease

The administration of an anticoagulant in patients with liver disease (nonalcoholic steatohepatitis—NASH, nonalcoholic fatty liver disease—NAFLD, chronic hepatitis, or cirrhosis) who have an indication (atrial fibrillation, venous thrombosis, or pulmonary embolism) is challenging because there is an...

Full description

Bibliographic Details
Main Authors: Raluca S. Costache, Andreea S. Dragomirică, Bogdan E. Gheorghe, Vasile D. Balaban, Silviu M. Stanciu, Mariana Jinga, Daniel O. Costache
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Medicina
Subjects:
liver disease
VKAs
DOACs
atrial fibrillation
venous thrombosis
Online Access:https://www.mdpi.com/1648-9144/59/2/346

Internet

https://www.mdpi.com/1648-9144/59/2/346

Similar Items